| Therapeutic potential of foldamers: from chemical biology tools to drug candidates? R Gopalakrishnan, AI Frolov, L Knerr, WJ Drury III, E Valeur Journal of Medicinal Chemistry 59 (21), 9599-9621, 2016 | 174 | 2016 |
| Targeted delivery of antisense oligonucleotides to pancreatic β-cells C Ämmälä, WJ Drury III, L Knerr, I Ahlstedt, P Stillemark-Billton, ... Science advances 4 (10), eaat3386, 2018 | 173 | 2018 |
| O-Glycosyl Trichloroacetimidates Bearing Fmoc as Temporary Hydroxy Protecting Group: A New Access to Solid-Phase Oligosaccharide Synthesis F Roussel, L Knerr, M Grathwohl, RR Schmidt Organic letters 2 (20), 3043-3046, 2000 | 89 | 2000 |
| The conundrum of GSK3 inhibitors: is it the dawn of a new beginning? RV Bhat, U Andersson, S Andersson, L Knerr, U Bauer, ... Journal of Alzheimer's Disease 64 (s1), S547-S554, 2018 | 83 | 2018 |
| Late‐stage functionalization of histidine in unprotected peptides AFM Noisier, MJ Johansson, L Knerr, MA Hayes, WJ Drury III, E Valeur, ... Angewandte Chemie 131 (52), 19272-19278, 2019 | 65 | 2019 |
| Glucagon like peptide 1 receptor agonists for targeted delivery of antisense oligonucleotides to pancreatic beta cell L Knerr, TP Prakash, R Lee, WJ Drury III, M Nikan, W Fu, E Pirie, LD Maria, ... Journal of the American Chemical Society 143 (9), 3416-3429, 2021 | 55 | 2021 |
| T-type calcium channels inhibitors: a patent review F Giordanetto, L Knerr, A Wållberg Expert opinion on therapeutic patents 21 (1), 85-101, 2011 | 55 | 2011 |
| Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion F Giordanetto, JD Revell, L Knerr, M Hostettler, A Paunovic, C Priest, ... ACS medicinal chemistry letters 4 (12), 1163-1168, 2013 | 52 | 2013 |
| Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold–small molecule interactions HS Haniff, L Knerr, X Liu, G Crynen, J Boström, D Abegg, A Adibekian, ... Nature chemistry 12 (10), 952-961, 2020 | 51 | 2020 |
| New synthetic pathway to diverse 2-substituted quinolines based on a multicomponent reaction: solution-phase and solid-phase applications T Demaude, L Knerr, P Pasau Journal of Combinatorial Chemistry 6 (5), 768-775, 2004 | 51 | 2004 |
| Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents AT Plowright, O Engkvist, A Gill, L Knerr, QD Wang Angewandte Chemie International Edition 53 (16), 4056-4075, 2014 | 46 | 2014 |
| Application of a ring closing metathesis based linker to the solid phase synthesis of oligosaccharides L Knerr, RR Schmidt Synlett 1999 (11), 1802-1804, 1999 | 46 | 1999 |
| Development of novel melanocortin receptor agonists based on the cyclic peptide framework of sunflower trypsin inhibitor-1 T Durek, PM Cromm, AM White, CI Schroeder, Q Kaas, J Weidmann, ... Journal of medicinal chemistry 61 (8), 3674-3684, 2018 | 39 | 2018 |
| Exploring physicochemical space via a bioisostere of the trifluoromethyl and ethyl groups (BITE): attenuating lipophilicity in fluorinated analogues of Gilenya® for multiple … N Erdeljac, G Kehr, M Ahlqvist, L Knerr, R Gilmour Chemical Communications 54 (85), 12002-12005, 2018 | 39 | 2018 |
| Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease F Giordanetto, D Pettersen, I Starke, P Nordberg, M Dahlström, L Knerr, ... ACS Medicinal Chemistry Letters 7 (10), 884-889, 2016 | 39 | 2016 |
| Target-directed approaches for screening small molecules against RNA targets HS Haniff, L Knerr, JL Chen, MD Disney, HL Lightfoot SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (8), 869-894, 2020 | 34 | 2020 |
| Fluorine‐Directed Glycosylation Enables the Stereocontrolled Synthesis of Selective SGLT2 Inhibitors for Type II Diabetes A Sadurní, G Kehr, M Ahlqvist, J Wernevik, HP Sjögren, C Kankkonen, ... Chemistry–A European Journal 24 (12), 2832-2836, 2018 | 33 | 2018 |
| Stereocontrolled Synthesis of Tetrafluoropentanols: Multivicinal Fluorinated Alkane Units for Drug Discovery P Bentler, N Erdeljac, K Bussmann, M Ahlqvist, L Knerr, K Bergander, ... Organic letters 21 (19), 7741-7745, 2019 | 28 | 2019 |
| Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity W McCoull, P Barton, A Broo, AJH Brown, DS Clarke, G Coope, ... MedChemComm 4 (2), 456-462, 2013 | 27 | 2013 |
| Novel, acidic CCR2 receptor antagonists: from hit to lead D Zou, HX Zhai, J Eckman, P Higgins, M Gillard, L Knerr, S Carre, ... Letters in Drug Design & Discovery 4 (3), 185-191, 2007 | 26 | 2007 |
